质子泵抑制剂可以治疗顽固性胃灼热。
Proton pump inhibitors can tackle really stubborn heartburn.
质子泵抑制剂的应用是酸相关疾病的标准治疗。
Proton pump inhibitor (PPI) is considered as the standard treatment for acid-related disorders.
质子泵抑制剂和氯吡格雷的相互作用：是真是假？
Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?
目的：为质子泵抑制剂的合理应用作一全面的评述。
OBJECTIVE: To make a comprehensive comment on rational use of proton-pump inhibitors.
这种质子泵抑制剂已经被批准用于12岁至17岁的青少年。
This proton pump inhibitor was already approved for adolescents between the ages of 12 to 17.
本发明涉及质子泵抑制剂的碱性盐和包含这些化合物的药物。
The invention relates to alkaline salts of proton pump inhibitors and to medicaments comprising these compounds.
大多数病例在低镁血症得到治疗后没有继续使用质子泵抑制剂。
In most cases reviewed the patients did not continue on PPIs after the hypomagnesemia was treated.
迄今为止每个质子泵抑制剂都被研究开发为一个前药的管理形式。
Every proton pump inhibitor so far developed is administered in a prodrug form.
雷贝拉唑比前期上市的其他质子泵抑制剂可以更快速的发挥作用。
Rabeprazole exerts its action much more quickly than the other proton pump inhibitors previously developed.
目的探讨质子泵抑制剂（PPI）对胰腺外分泌是否有直接影响。
Objective To study the direct effect of PPI on pancreatic exocrine by isolated pancreatic acini.
一个最近的药物进化的例子是抑制胃酸分泌的质子泵抑制剂的进化。
One of the recent examples of such drug evolution is proton pump inhibitors that inhibit gastric acid secretion.
该制剂包括含有质子泵抑制剂与乙酰水杨酸组合的固定的口服剂型。
The present preparation comprises a fixed oral dosage form comprising a proton pump inhibitor in combination with acetyl salicylic acid.
埃索美拉唑是新一代质子泵抑制剂成员，有较强的抑制胃酸分泌效应。
Esomeprazole is a new member of proton pump inhibitors (PPI) with strong suppressive effects on gastric acid secretion.
在市场上买的质子泵抑制剂用来治疗频发的烧心症时只能使用14天。
Over-the-counter PPIs should be taken for only 14 days for treatment of frequent heartburn.
每天服用质子泵抑制剂的病人受感染的风险比不服用药物的增加了74%。
Patients taking PPIs daily had a 74% increased risk compared with those not taking the drugs.
雷贝拉唑是一种新型的质子泵抑制剂，广泛应用于消化系统疾病的治疗。
Rabeprazole is a new type of Proton Pump Inhibitors, which is widely used in therapy for digestive system illness.
观察质子泵抑制剂和促动力药预防和治疗反流性食管炎及出血的重要性。
Observed the importance of using proton-pump inhibitor (PPI) and gastrointestinal prokinetic drug for treatment of re and prevention of bleeding.
质子泵抑制剂，可以处方和非处方取药，主要通过减少胃酸量而发挥作用。
Proton pump inhibitors, available by prescription and over-the-counter (OTC), work by reducing the amount of acid in the stomach.
目的观察质子泵抑制剂埃索美拉唑是否影响氯吡格雷的抗血小板聚集作用。
Objective to observe the influence of proton pump inhibitor (PPI) esomeprazole on antiplatelet effect of clopidogrel.
本发明涉及用于治疗气道病症的可逆的质子泵抑制剂和气道治疗剂的组合。
The invention relates to the combination of reversible proton pump inhibitors and airway therapeutics for the treatment of airway disorders.
联邦机构将会要求把这个警告加到处方与非处方质子泵抑制剂的包装标签上。
The federal agency will now require the warning to be added to the package labels of both the prescription and nonprescription versions of the drugs.
结论：质子泵抑制剂可有效治疗酸相关性疾病，值得临床进一步应用、推广。
Conclusion: proton pump inhibitors can be effective in the treatment of acid correlation disease, is worth further clinical application and promotion.
如果您长期使用非处方药类质子泵抑制剂，请务必告知您的医疗保健专业人员。
Make sure your healthcare professional knows if you have been taking an OTC PPI drug for a long period of time.
每天服用质子泵抑制剂一次以上的患者受感染的风险也会加倍，而且会导致严重腹泻。
Patients taking a more-than-once-a-day PPI dose more than doubled their risk of getting C. diff, an infection that can cause severe diarrhea.
当决定质子泵抑制剂用于治疗时，卫生保健专业人员和消费者应权衡这些药物的利弊。
Health care professionals and consumers should weigh the known benefits against the potential risks of proton pump inhibitors when determining if these medications are appropriate for treatment.
艾司奥美拉唑是一种新型的质子泵抑制剂， 它是奥美拉唑的S-型光学异构体。
Esomeprazole, a new proton pump inhibitor, is the S - isomer of omeprazole.
处方的警告和注意事项，非处方质子泵抑制剂的药品事实说明书将对这些结果进行说明。
Both the Warnings and Precautions section of the prescription labeling and the Drug Facts label on OTC proton pump inhibitors will address these findings.
兰索拉唑(LPZ)是近年来开发并已被广泛用于治疗胃酸相关性疾病的新型质子泵抑制剂。
Lansoprazole (LPZ) that has been widely used for the treatment of acid-related diseases is a relatively novel class of proton pump inhibitors (PPIs).
结论H 2受体拮抗剂能够诱导壁细胞H 2受体出现脱敏，质子泵抑制剂未出现耐受现象。
Conclusion: H_2 receptor antagonists induce the desensitization of the H2 receptor on the the rat gastric parietal cell, but proton pump inhibitors do not have tolerance.
本发明涉及药物制剂领域，具体涉及含取代苯并咪唑质子泵抑制剂的组合物及其制备方法。
The present invention belongs to the field of medicine preparation, in the concrete, it relates to a composition of substituted benzimidazole proton pump inhibitor and its preparation method.
应用推荐